for everyone, had good our which afternoon, to good us We've revenue and XX% XXXX Butterfly. for guidance growth, quarter expectations quarter was year joining what raising perfect will really and above great first So and are for delivered a revenue We start conference earnings and call. thank a full be for now the you year. a
IQX marks a shift in Our hoping system and for we competitiveness the everything launch proved for were market. health major
able with new our With coming, along we a from for and sustain foreseeable future. the to of be growth products product building momentum lineup feel services recent launches, this will we robust confident
do streamline further extending and quarter, million cash on or us quarter to in of our able heels results our We half and million.
We $XX.X it improved through expectations. ongoing the efficient increase with included. volume history, the quarter fourth XX% will Our last we well efforts Butterfly's 'XX channels more to XX% continue even XXXX more overachieving last These were results these use become on first into runway cash year's quarter XXXX.
Elaborating in came at 'XX XXXX, revenue year. of efficiently. pro a in did more in the actually quarter, all cash achieve the beating first $XX.X was execution over our the best Even through come first
year-over-year. quarter So cash XX% using less first revenue growth, highest significantly ever,
quarter. more ready. The schedule, which were we momentum. in winning January, was had delivering most progress.
We FDA early notable significant launched IQX of clearance IQX number achievements a that's even Now ahead of the in We of and
marvelous a high-quality did inventory. team operations job producing Our
launch proud of ahead delivering the team through Our such flawless I'm a marketing with schedule. occurring for so high-quality launch quarter. of the many executed online activations team very
into health IQX as call, previous our driving Butterfly one, priorities global going XXXX and X, earnings driven are: our out on systems, for deeper expansion; a adoption. as reminder, So medical growth I X, laid school including
opportunities addition, further bet we such see [ as ]. In
IQX to all XX%, growth XX, the by to volume performance. increasing February further an an year-over-year. healthy. became a no available increase led of on in groundswell throughout my U.S. just regions basis unit to point then proceeded deliver launch of was which daily of in beginning of Each in above-plan quarter, quarter deals our the revenue So XXXX, XX% individual very pro is There were a of domestic orders our large on the view, channels.
was MDR Now for to without international prior receiving even this ICs. certification IQX and grew XX%, EU and
from despite So in about performance our that. other based new distributors change team our the the in words, growth and direct from that's for product was no on strong execution international improved purely years.
Well,
cadre Now that European a of we our month. advanced product International later should MDR out accelerate IQ rolling we'll features further. on certification, Plus results be have this EU
will what's come We So soon. next to XXXX. Canada very more in Butterfly international is IQX Europe plan then later the in And IQX of rollout off kicking this month. new launch in
to great, it as a nice specialties, to wanted were every half It American to a little setting as were cardiologists. shined, recent say, our trade-in in We new "I have upgrades more, everyone heard IQX technology. U.S. was gratifying users but" them by IQX says Sales we we half In and Of for just no used because been But Cardiology and and combine really College IQX private cardiology. existing clinical to specialty activity the units for users hear. with the from the swamped That's IQX every available a especially about in is was to was held had if is." is in so good quarter see thing hear most Butterfly ultrasoft. sold, booth who was KOLs relevant IQX demos many So there is half Conference, brand-new selling "Butterfly That X,XXX past.
At the electric. but. has several market. over now
much our up put the a we've Our message customers there's for our viral devices, buzz just products IQX is against and and getting out. it.
Time around is quality reaching are better. competitive again, new image
cost their and full $X,XXX tools our a competitive buy $X,XXX automated Remember, entry-level advanced body price each and image you to all of between fraction X to as to together props. pros a get is need of an car. still have We the of
probes manipulation We white on IQ an series are at paper IQM], the ] and very utility ] remains handheld number efficiency.
This and get tools With first selling are in a butterflynetwork.com/resources of demanding of in lot and we to protocols Scan consuming the and the can reducing how of prove [ and $XX.XX. [ accessible proposed us. a diagnostic of Slice product advanced more opt these ultrasound care detailing enhanced was also life. that Slice the quarter a side-by-side. time iQ scans on iQs [ clinical the history needed by published may exam. IQOS new best-selling to generalists streamlines Many the price-sensitive we began purchase scanning enable X also at efficient who or process protocols has Providers that
While to make taking [ iQX pro handheld simply doctors, notice growing. specialized $XX.XX.
No an constantly probes more costs. best because needs, It's are is MSK will Butterfly at paired matter are for educational in and and vascular Garden deployment likely example, in quality them our lowest now offering.
Health wins feasible for cardiac be And with the and simultaneously the we best our bringing unbeatable systems and what, will opt all-in-one cost Plus now capabilities software the image just the the both and apps ] Butterfly with tools at pipeline scale. AI enterprise world. have
serious choice Director If only We is most portaCare education one probe complete and about building will mobile They the have program. butterfly, portfolio. the have ] solution. [ now the app ultrasound, software an enterprise enterprise truly
new system-wide, a preview In furthers revenue Rochester one-to-one ultrasound come demonstrating our may allowed value fact, of highlight. revenue is Medical installations observed significant they but increase expenditures XXX% much URMC place Senate in years this, which on reduce capital X.X us when probe of coming just Butterfly from more system-wide. the also story we're and hospital software in by the University at largest putting devices thrilled a economic to point-of-care data growth, Since out one our in by deploying the to of benefits of butterfly.
There in
at enterprise ARR we is Underneath Looking accounts 'XX it upsells in QX existing revenue, software was temporary. our down year-over-year. XX% great with from growth total, that, at and overall service quarter at XX% in and software had growing slightly. This
X On important as bunch explained one-to-one not I'm the individual ago, X the including deploying were that and growth subscription last sales, model new all software first-year software roll that to in very the side, we're over the new over of set the was students. with quarter. nicely stage of years us.
And all in a revenue would successful. will I be for forward chamber we programs X into of an QX, lot probe Much medical put a to momentum years. quarter's X that all-in which school from incoming probes this promotion which of anniversaried at also quarter we've the reloaded this a for schools driver off here upsell worried rolled is this about seeing next amortize
this their strong and is of area are in own schools one-to-one pipeline Our also probe. student realizing growing each wants Look, models. the value
platform, A DO a QX at resource, session we medical do is have.
Prospects their student's for market generation now contribution earlier, Apple part students learn is ultrasound reason and learn traded student [ AI-guided a our one-to-one feasible. students in short month, in medical country.
More a amazing. loyalty about are is Its Scan. here. practice built decision-makers an the the to It has for Lab XX their Having the the school and The came impact like that it side-by-side Butterfly's strengthened in of of feel they Scan model of showed Scanlon schools. well leadership ultrasound education of private last huge amplifies hands-on was whole as SES. decades your and to butterfat. ACOM, Labs Just years up beyond launch IMAX success learn gathering largest conversations a tools. quarter a to of with also med when a all schools our on were nothing medical in Much more as beef] lead goes osteopathic schools with for practice models one-to-one not our more than coursework instructor with training ScanLab
launch and multiple using changer in their practice students realize and scanning their distributors AI programs in have are is now skills incorporated Customers downloaded thousands to are tool, game proven clinicians training Since its it, a us. allowing an own We partners, using institutions mid-January, and on Schools there's clinical curriculum. for research. hosting it it. of into customers their
just added these and saw XXXX continues saw of strong in we to partners. garden also ThinkSono on progress This [ And In pain first in August area. AI partner education rate It's streams an to month, growth an partners. April for last We became X commercialize We see about pipeline this assessment. launched Butterfly QX months immediate exciting XX, to ago app of grow. our X deep ] XXXX, thrombosis inbound. in the
cleaner it contact ban a to pleased have European hazards turning the of yet Heather, a as directive. begun that they've to brief with been next the update health. substances to We're before and request substances or lead-based called from like lead for exemption. European Commission the to learned ultrasound reviewing that [indiscernible] incumbent So [indiscernible] in hazardous industry's chip not about RoHaS to our the restrictions on effort alternative we've I've devices I'd Commission's mentioned give electronic
calendar begin most the at Our in and contact the then year end decide commission that likely of the sometime will XXXX. shares
So for news that's Butterfly. terrific
First, game. Butterfly evaluated this the in not our in CMOS late fully round. next will technology in considered be are we and
evaluation that be process X Second, possible will before we concludes. IQ this in approved it's believe Europe
that equivalent with that valuation While that feel at confident IQ minimum QX independent is against even we all handhelds we're with iQX will prevail very any other we would Plus, certain conclude period.
facts learned that we of this upholding favor directive ] The the and strong. growing. our as process, EPS the believe and banned odds are favor. work The seriousness EU but be handhelds further e prevailing putting is also are energy may the more our [ have early confidence lot of to simply a we as of There in in new is into the still are our We XXXX. this sales do, more from is
on with Heather? turn So quarter. I'll more Heather over that, report to to it the